These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 37998328)

  • 1. CRISPR-Cas System Is an Effective Tool for Identifying Drug Combinations That Provide Synergistic Therapeutic Potential in Cancers.
    Kim Y; Lee HM
    Cells; 2023 Nov; 12(22):. PubMed ID: 37998328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic applications and therapeutic option of Cascade CRISPR/Cas in the modulation of miRNA in diverse cancers: promises and obstacles.
    Alinejad T; Modarressi S; Sadri Z; Hao Z; Chen CS
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):9557-9575. PubMed ID: 37222810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the CRISPR-Cas system in cancer drug development: Mechanisms of action and therapy.
    Chandrasekaran AP; Karapurkar JK; Chung HY; Ramakrishna S
    Biotechnol J; 2022 Jul; 17(7):e2100468. PubMed ID: 35157790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applications of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) as a Genetic Scalpel for the Treatment of Cancer: A Translational Narrative Review.
    Mondal R; Brahmbhatt N; Sandhu SK; Shah H; Vashi M; Gandhi SK; Patel P
    Cureus; 2023 Dec; 15(12):e50031. PubMed ID: 38186450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of CRISPR/Cas systems for cancer gene therapy and immunotherapy.
    Song X; Liu C; Wang N; Huang H; He S; Gong C; Wei Y
    Adv Drug Deliv Rev; 2021 Jan; 168():158-180. PubMed ID: 32360576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement.
    Li C; Brant E; Budak H; Zhang B
    J Zhejiang Univ Sci B; 2021 Apr; 22(4):253-284. PubMed ID: 33835761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-Cas system: a powerful tool for genome engineering.
    Liu L; Fan XD
    Plant Mol Biol; 2014 Jun; 85(3):209-18. PubMed ID: 24639266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas Advancement in Molecular Diagnostics and Signal Readout Approaches.
    Ahmed MZ; Badani P; Reddy R; Mishra G
    J Mol Diagn; 2021 Nov; 23(11):1433-1442. PubMed ID: 34454111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/Cas9 for overcoming drug resistance in solid tumors.
    Saber A; Liu B; Ebrahimi P; Haisma HJ
    Daru; 2020 Jun; 28(1):295-304. PubMed ID: 30666557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR Cas System: An efficient tool for cancer modelling.
    Akhtar M; Jamal T; Khan M; Khan SR; Haider S; Jalil F
    J Pak Med Assoc; 2021 Feb; 71(2(B)):718-724. PubMed ID: 33941966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Perspective on the Future of High-Throughput RNAi Screening: Will CRISPR Cut Out the Competition or Can RNAi Help Guide the Way?
    Taylor J; Woodcock S
    J Biomol Screen; 2015 Sep; 20(8):1040-51. PubMed ID: 26048892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR/Cas9: a powerful tool for identification of new targets for cancer treatment.
    Liu B; Saber A; Haisma HJ
    Drug Discov Today; 2019 Apr; 24(4):955-970. PubMed ID: 30849442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress and challenges towards CRISPR/Cas clinical translation.
    Rosenblum D; Gutkin A; Dammes N; Peer D
    Adv Drug Deliv Rev; 2020; 154-155():176-186. PubMed ID: 32659256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
    Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
    J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPER/Cas in Plant Natural Product Research: Therapeutics as Anticancer and other Drug Candidates and Recent Patents.
    Dey A; Nandy S
    Recent Pat Anticancer Drug Discov; 2021; 16(4):460-468. PubMed ID: 34911411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR-Cas9 for cancer therapy: Opportunities and challenges.
    Chen M; Mao A; Xu M; Weng Q; Mao J; Ji J
    Cancer Lett; 2019 Apr; 447():48-55. PubMed ID: 30684591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas9 for cancer treatment: technology, clinical applications and challenges.
    Cheng X; Fan S; Wen C; Du X
    Brief Funct Genomics; 2020 May; 19(3):209-214. PubMed ID: 32052006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of CRISPR-Cas systems using phage-based vectors.
    Fage C; Lemire N; Moineau S
    Curr Opin Biotechnol; 2021 Apr; 68():174-180. PubMed ID: 33360715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of CRISPR-Cas in advancing precision periodontics.
    Barbour A; Glogauer J; Grinfeld L; Ostadsharif Memar R; Fine N; Tenenbaum H; Glogauer M
    J Periodontal Res; 2021 Jun; 56(3):454-461. PubMed ID: 33452819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR/Cas9-based Gene Therapies for Fighting Drug Resistance Mediated by Cancer Stem Cells.
    Dashtaki ME; Ghasemi S
    Curr Gene Ther; 2023; 23(1):41-50. PubMed ID: 36056851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.